Stanislas Pol
Impact in
- Hepatology top 0.01%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 0.02%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 467
- Hepatitis C virus research 417
- Liver Disease and Transplantation 47
- Hepatitis Viruses Studies and Epidemiology 26
- Epidemiology 329
- Hepatitis B Virus Studies 222
- Liver Disease Diagnosis and Treatment 218
- Co-authors
- Anaïs Vallet‐Pichard (72 shared papers)Bertrand Nalpas (53 shared papers)Vincent Olivier Mallet (76 shared papers)Christian Bréchot (54 shared papers)Hélène Fontaine (39 shared papers)Virginie Verkarre (7 shared papers)Valérie Dhalluin-Venier (3 shared papers)Patrice Cacoub (57 shared papers)
- Journals
- Journal of Hepatology (107 papers)Hepatology (47 papers)Journal of Viral Hepatitis (29 papers)Liver International (28 papers)Gastroenterology (23 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Stanislas Pol
611 papers receiving 32.2k citations
Stanislas Pol's Hit Papers
Peers
Comparison fields: 5 of 168
- Hepatology 21.3k
- Epidemiology 17.2k
- Infectious Diseases 4.6k
- Transplantation 418
- Virology 505
Countries citing papers authored by Stanislas Pol
This map shows the geographic impact of Stanislas Pol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislas Pol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislas Pol more than expected).
Fields of papers citing papers by Stanislas Pol
This network shows the impact of papers produced by Stanislas Pol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislas Pol. The network helps show where Stanislas Pol may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanislas Pol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 635 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2063 |
| 2 | FIB-4 Hit paper breakdown → | 2007 | 1777 |
| 3 | Telaprevir for Retreatment of HCV Infection Hit paper breakdown → | 2011 | 1272 |
| 4 | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Hit paper breakdown → | 2019 | 1063 |
| 5 | Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection Hit paper breakdown → | 2009 | 856 |
| 6 | Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles Hit paper breakdown → | 2002 | 566 |
| 7 | Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study Hit paper breakdown → | 2015 | 553 |
| 8 | Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study Hit paper breakdown → | 2019 | 498 |
| 9 | 2001 | 492 | |
| 10 | Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients Hit paper breakdown → | 2014 | 404 |
| 11 | Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis Hit paper breakdown → | 2017 | 376 |
| 12 | Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890 Hit paper breakdown → | 2013 | 374 |
| 13 | 2011 | 352 | |
| 14 | Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection Hit paper breakdown → | 2018 | 340 |
| 15 | 2011 | 337 | |
| 16 | Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment Hit paper breakdown → | 2017 | 317 |
| 17 | 2007 | 275 | |
| 18 | 2012 | 255 | |
| 19 | 2015 | 249 | |
| 20 | 2014 | 248 |
About Stanislas Pol
Stanislas Pol is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Immunology, having authored 635 papers that have together received 33.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (417 papers), Hepatitis B Virus Studies (222 papers), Liver Disease Diagnosis and Treatment (218 papers), Systemic Lupus Erythematosus Research (50 papers), Liver Disease and Transplantation (47 papers), HIV/AIDS drug development and treatment (43 papers), Hepatitis Viruses Studies and Epidemiology (26 papers) and Chronic Lymphocytic Leukemia Research (20 papers). The work is most often cited by research in Hepatology (21.3k citations), Epidemiology (17.2k citations), Infectious Diseases (4.6k citations), Transplantation (418 citations) and Virology (505 citations). Stanislas Pol has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Anaïs Vallet‐Pichard, Bertrand Nalpas, Vincent Olivier Mallet, Christian Bréchot, Hélène Fontaine, Virginie Verkarre, Valérie Dhalluin-Venier, Patrice Cacoub, Marc Bourliere and Valérie Thiers. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Viral Hepatitis, Liver International and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.